Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review-Reference-Cited by-同舟云学术

Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review

Published:2023-12-21 Issue: Volume: Page:
ISSN:2192-3183
Container-title:International Cancer Conference Journal
language:en
Short-container-title:Int Canc Conf J

Author:

Ushijima Futoshi,Hase Tetsunari^ORCID,Yamashita Yuki,Kim Hangsoo,Shimokata Tomoya,Kondo Chiaki,Sato Tomonori,Baba Tomoya,Watanabe Shohei,Futamura Keisuke,Ando Yuichi,Mizuno Masashi,Ishii Makoto

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s13691-023-00640-8.pdf

Reference31 articles.

1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

2. Oronsky B, Reid TR, Oronsky A, Carter CA (2017) What’s new in SCLC? A review. Neoplasia 19:842–847. https://doi.org/10.1016/j.neo.2017.07.007

3. Wang S, Tang J, Sun T et al (2017) Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages. Sci Rep 7:1339. https://doi.org/10.1038/s41598-017-01571-0

4. Byers LA, Rudin CM (2015) Small cell lung cancer: where do we go from here? Cancer 121:664–672. https://doi.org/10.1002/cncr.29098

5. Paz-Ares L, Dvorkin M, Chen Y et al (2019) Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet 394:1929–1939. https://doi.org/10.1016/s0140-6736(19)32222-6

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carboplatin/durvalumab/etoposide;Reactions Weekly;2024-01-13